Sort
21,281 grants matching “influenza”
Respiratory Virus Vaccine and Adjuvant Exploration
$1,000,000Ralph S Baric · Univ Of North Carolina Chapel Hill · U01 · FY2019 · AI
Surveillance and Response to Avian and Pandemic Influenza by Regional Offices....
$1,000,000Adamou A. Yada · World Health Organization--Afro · U51 · FY2008 · CI
African Americans in Health Science Research: A University, Community, and Faith-
$1,000,000Kathy J Goggin · University Of Missouri Kansas City · RC4 · FY2010 · MD
Strengthening Influenza Surveillance (WHO/EMRO)
$1,000,000Hassan El-Mahdi El-Bushra · World Hlth Org- -E Mediterranean Office · U51 · FY2009 · CI
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** INFECTIOUS DISEASES AND HEAT STRESS, EXACERBATED BY CLIMATE CHANGE, ARE TWO SIGNIFICANT CHALLENGES FACING THE $34.68B US EGG INDUSTRY. HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI) OUTBREAKS IN THE U.S. IN 2014-2015 AND 2022 RESULTED IN LOSSES OF 57M AND 43M BIRDS, RESPECTIVELY. THE MANDATORY CONVERSION OF 66% HEN INVENTORY FROM CONVENTIONAL CAGED TO CAGE-FREE HOUSING BY 2026 WORSENS THE ABOVE CHALLENGES. ADVISED BY A BOARD OF EGG SUPPLY-CHAIN STAKEHOLDERS, THIS MULTIDISCIPLINARY TEAM, WITH EXPERTISE IN SCIENCE AND ENGINEERING TECHNOLOGIES FOR POULTRY HEALTH AND PERFORMANCE, AIMS TO DEVELOP HOLISTIC INTERVENTIONS TO ABATE DISEASES AND HEAT-STRESS IN CAGE-FREE EGG HOUSING. OUR OBJECTIVES ARE TO DEVELOP INTEGRATED RESEARCH, EXTENSION AND EDUCATION PROGRAMS TO: (1) ENGAGE STAKEHOLDERS TO ASSESS CHALLENGES AND NEEDS IN CAGE-FREE EGG PRODUCTION; (2) DEVELOP HOLISTIC INTERVENTIONS TO ENHANCE BIRD PERFORMANCE AND RESISTANCE TO DISEASES; (3) DEVELOP INNOVATIVE VENTILATION TO ABATE HEAT STRESS AND DISEASE TRANSMISSION; AND (4) EQUIP EGG FARMERS WITH THE KNOWLEDGE AND TOOLS DEVELOPED AND EMPOWER FUTURE WORKFORCE VIA MULTIDISCIPLINARY EDUCATION. THE PROJECT OUTCOMES INCLUDE (1) NEW KNOWLEDGE OF THE MICROBIOME IN CAGE-FREE HOUSING AND EFFECTIVE INTERVENTIONS TO IMPROVE HEN HEALTH, IMMUNITY, AND PERFORMANCE; (2) NEW VENTILATION TO ABATE HEAT STRESS AND DISEASE TRANSMISSION; (3) TRANSLATIONAL EXTENSION PROGRAMS TO ENABLE FARMERS TO PROTECT HEN HEALTH; AND (4) MULTIDISCIPLINARY CURRICULA FOR FUTURE WORKFORCE. THIS PROJECT ADDRESSES THE FIRST TWO PROGRAM AREA PRIORITIES OF THE USDA AFRI IDEAS GRANT PROGRAM: PRECISION ANIMAL MANAGEMENT AND ENVIRONMENTAL SYNERGIES OF ANIMAL PRODUCTION. IT WILL CONTRIBUTE TO HEALTHY AND SUSTAINABLE EGG PRODUCTION IN THE U.S.
$1,000,000Ohio State University, The · · FY2023 · National Institute of Food and Agriculture
MULTISITE EPIDEMIOLOGICAL AND VIROLOGICAL MONITORING OF INFLUENZA VIRUS SURVEILLA
$1,000,000Devendra Tarachand Mourya · Indian Council Of Medical Research · U51 · FY2011 · IP
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2017 · AI
The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Pers
$1,000,000Kathryn Margaret Edwards · Vanderbilt University · U18 · FY2009 · IP
Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.
$1,000,000Christopher H Clegg · Tria Bioscience Corporation · R44 · FY2012 · AI
Novel anti-viral agents to treat influenza
$1,000,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R44 · FY2014 · AI
Novel anti-viral agents to treat influenza
$1,000,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R44 · FY2013 · AI
PIPP Phase I: Advancing Environmental Surveillance for Pandemic Prediction in Remote and Resource Poor Settings
$1,000,000Scott Berry · University Of Kentucky Research Foundation · · FY2022 · CSE
Non-Human Primate Lymphoid Organ Chips for Vaccine Assessment
$1,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
PIPP Phase I: Heterogeneous Model Integration for Infectious Disease Intelligence
$1,000,000John M Drake · University Of Georgia Research Foundation Inc · · FY2022 · BIO
PIPP Phase 1: International Center for Avian Influenza Pandemic Prediction and Prevention
$999,999Xiangming Xiao · University Of Oklahoma Norman Campus · · FY2022 · CSE
Preclinical development of a potent D-peptide RSV inhibitor
$999,998Brett D Welch · Navigen, Inc. · R44 · FY2017 · AI
NYC Center of Excellence for Public Health Informatics
$999,998Farzad Mostashari · New York City Health/Mental Hygiene · P01 · FY2007 · CD
Preclinical development of a potent D-peptide RSV inhibitor
$999,998Brett D Welch · Navigen, Inc. · R44 · FY2018 · AI
NYC Center of Excellence for Public Health Informatics
$999,998Farzad Mostashari · New York City Health/Mental Hygiene · P01 · FY2006 · CD
A single antiviral to treat multiple opportunistic infections
$999,998Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2023 · AI
A single antiviral to treat multiple opportunistic infections
$999,997Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2019 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine
$999,993Christopher Locher · Versatope Therapeutics, Inc. · R44 · FY2025 · AI
CMC of Peptide Formulation for the Treatment of ARDS
$999,993Gerardo M. Castillo · Pharmain Corporation · R44 · FY2022 · HL
Point of Care Flu Drug Resistance Test
$999,992Xing-Xiang Li · Cellex, Inc. · R44 · FY2011 · AI
Point of Care Flu Drug Resistance Test
$999,989Xing-Xiang Li · Cellex, Inc. · R44 · FY2010 · AI